Cargando…
QTc Prolongation in SARS-CoV-2 (COVID-19) Patients Receiving Hydroxycloroquine: A Retrospective Study
Background and Aims Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has infected more than 153 million people and led to the death of 3.3 million others. The absence of an effective treatment other than vaccination, has led clinicians in the beginning t...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Mosby, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556499/ http://dx.doi.org/10.1016/j.ahj.2021.10.018 |